Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Colorectal Neoplasms

  Free Subscription


1 Ann Surg
1 Ann Surg Oncol
6 Anticancer Res
3 BMC Cancer
1 BMC Gastroenterol
4 Br J Cancer
1 Br J Surg
1 Cancer
1 Cancer Res
1 Clin Cancer Res
2 Dig Dis
2 Eur J Surg Oncol
5 Gastroenterology
2 Gut
1 Int J Oncol
1 J Natl Cancer Inst
1 Lancet Gastroenterol Hepatol
1 Oncogene
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg

  1. JONES EL, Halpern AL, Carmichael H, Wikiel KJ, et al
    Hepatic Ablation Promotes Colon Cancer Metastases in an Immunocompetent Murine Model.
    Ann Surg. 2019 Jul 23. doi: 10.1097/SLA.0000000000003474.
    PubMed     Text format     Abstract available

    Ann Surg Oncol

  2. SHIDA D
    ASO Author Reflections: Prognostic Impact of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer.
    Ann Surg Oncol. 2019 Jul 29. pii: 10.1245/s10434-019-07666.
    PubMed     Text format    

    Anticancer Res

  3. YOON SN, Park JH, Lwin TM, Miyake K, et al
    Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
    Anticancer Res. 2019;39:4065-4071.
    PubMed     Text format     Abstract available

  4. HISAKA T, Ishikawa H, Sakai H, Kawahara R, et al
    Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis.
    Anticancer Res. 2019;39:4549-4554.
    PubMed     Text format     Abstract available

  5. TAKIMOTO R, Kamigaki T, Okada S, Matsuda E, et al
    Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.
    Anticancer Res. 2019;39:4525-4532.
    PubMed     Text format     Abstract available

  6. ASHIZAWA N, Shimizu H, Sudo M, Furuya S, et al
    Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer.
    Anticancer Res. 2019;39:4405-4410.
    PubMed     Text format     Abstract available

  7. MATSUDA A, Yamada T, Matsumoto S, Sakurazawa N, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2019;39:4343-4350.
    PubMed     Text format     Abstract available

  8. ITO Y, Kobuchi S, Takesada W, Takahashi C, et al
    Assessment of Oxaliplatin-induced Chronic Neuropathy and Anticancer Efficacy Through Pharmacokinetic and Toxicodynamic Evaluation of a Rat Model of Colorectal Cancer.
    Anticancer Res. 2019;39:4207-4213.
    PubMed     Text format     Abstract available

    BMC Cancer

  9. SARASQUETA C, Perales A, Escobar A, Bare M, et al
    Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    BMC Cancer. 2019;19:735.
    PubMed     Text format     Abstract available

  10. IMAIZUMI J, Shida D, Narita Y, Miyakita Y, et al
    Prognostic factors of brain metastases from colorectal cancer.
    BMC Cancer. 2019;19:755.
    PubMed     Text format     Abstract available

  11. KIM E, Jung S, Park WS, Lee JH, et al
    Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
    BMC Cancer. 2019;19:302.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  12. ABRAHAM JM, Mahan K, Mettler T, Dunitz JM, et al
    Case report of synchronous post-lung transplant colon cancers in the era of colorectal cancer screening recommendations in cystic fibrosis: screening "too early" before it's too late.
    BMC Gastroenterol. 2019;19:137.
    PubMed     Text format     Abstract available

    Br J Cancer

  13. ELEZ E, Pericay C, Valladares-Ayerbes M, Bando I, et al
    A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
    Br J Cancer. 2019 Jul 31. pii: 10.1038/s41416-019-0537.
    PubMed     Text format     Abstract available

  14. PFUDERER PL, Ballhausen A, Seidler F, Stark HJ, et al
    High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.
    Br J Cancer. 2019 Jul 30. pii: 10.1038/s41416-019-0514.
    PubMed     Text format     Abstract available

  15. TAIEB J, Lapeyre-Prost A, Laurent Puig P, Zaanan A, et al
    Exploring the best treatment options for BRAF-mutant metastatic colon cancer.
    Br J Cancer. 2019 Jul 29. pii: 10.1038/s41416-019-0526.
    PubMed     Text format     Abstract available

  16. GORBUNOVA V, Beck JT, Hofheinz RD, Garcia-Alfonso P, et al
    Correction: A phase 2 randomised study of veliparib plus FOLFIRI+/-bevacizumab versus placebo plus FOLFIRI+/-bevacizumab in metastatic colorectal cancer.
    Br J Cancer. 2019 Jul 26. pii: 10.1038/s41416-019-0528.
    PubMed     Text format     Abstract available

    Br J Surg

  17. SEGELMAN J, Buchli C, Svanstrom Rojvall A, Matthiessen P, et al
    Effect of radiotherapy for rectal cancer on ovarian androgen production.
    Br J Surg. 2019;106:267-275.
    PubMed     Text format    


  18. ARNOLD CL, Rademaker AW, Morris JD, Ferguson LA, et al
    Follow-up approaches to a health literacy intervention to increase colorectal cancer screening in rural community clinics: A randomized controlled trial.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32398.
    PubMed     Text format     Abstract available

    Cancer Res

  19. TOME M, Pappalardo A, Soulet F, Lopez JJ, et al
    Inactivation of proprotein convertases in T cells inhibits PD-1 expression and creates a favorable immune microenvironment in colorectal cancer.
    Cancer Res. 2019 Jul 29. pii: 0008-5472.CAN-19-0086.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  20. LAZZARI L, Corti G, Picco G, Isella C, et al
    Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer.
    Clin Cancer Res. 2019 Aug 2. pii: 1078-0432.CCR-18-3440.
    PubMed     Text format     Abstract available

    Dig Dis

  21. PAVLOVIC-MARKOVIC A, Dragasevic S, Krstic M, Stojkovic Lalosevic M, et al
    Assessment of Duodenal Adenomas and Strategies for Curative Therapy.
    Dig Dis. 2019;37:374-380.
    PubMed     Text format     Abstract available

    Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
    Dig Dis. 2019;37:400-405.
    PubMed     Text format     Abstract available

    Eur J Surg Oncol

  23. STROUS MTA, Janssen-Heijnen MLG, Vogelaar FJ
    Impact of therapeutic delay in colorectal cancer on overall survival and cancer recurrence - is there a safe timeframe for prehabilitation?
    Eur J Surg Oncol. 2019 Jul 4. pii: S0748-7983(19)30546.
    PubMed     Text format     Abstract available

  24. SOARES AS, Lovat LB, Chand M
    Intracorporeal lymph node mapping in colon cancer surgery.
    Eur J Surg Oncol. 2019 Jul 16. pii: S0748-7983(19)30550.
    PubMed     Text format     Abstract available


  25. FISHER A, Podboy A, Pottathil V
    Once a Colon, Always a Colon.
    Gastroenterology. 2019;157:29-30.
    PubMed     Text format    

  26. FEHERVARI M, Prossor T, Kontovounisios C
    An Unusual Cause of Rectal Ischemia and Prolapse.
    Gastroenterology. 2019;157:25-26.
    PubMed     Text format    

  27. JASWANI TS, Hobson EM, Grider DJ
    A Complication of Crohn's Disease?
    Gastroenterology. 2019;157:31-33.
    PubMed     Text format    

  28. NEHME F, Atallah R, Palko W
    An Unusual Cause of Chest Pain.
    Gastroenterology. 2019;157:e13-e14.
    PubMed     Text format    

  29. LI J, Li J, Wang H, Qi LW, et al
    Tyrosine and Glutamine-Leucine Are Metabolic Markers of Early-Stage Colorectal Cancers.
    Gastroenterology. 2019;157:257-259.
    PubMed     Text format    


  30. REN J, Yao M
    Cautious view on the link between yoghurt consumption and risk of colorectal cancer.
    Gut. 2019 Jul 29. pii: gutjnl-2019-319430. doi: 10.1136/gutjnl-2019-319430.
    PubMed     Text format    

  31. WEI T, Luo P, Zhang X, Zhu W, et al
    Comparison of the incidence of colorectal cancer in young adults between the USA and Europe.
    Gut. 2019 Jul 31. pii: gutjnl-2019-319391. doi: 10.1136/gutjnl-2019-319391.
    PubMed     Text format    

    Int J Oncol

  32. WU F, Xing T, Gao X, Liu F, et al
    miR5013p promotes colorectal cancer progression via activation of Wnt/betacatenin signaling.
    Int J Oncol. 2019 Jul 30. doi: 10.3892/ijo.2019.4852.
    PubMed     Text format     Abstract available

    J Natl Cancer Inst

  33. BROWN JC, Caan BJ, Prado CM, Feliciano EMC, et al
    The Association of Abdominal Adiposity with Mortality in Patients with Stage I-III Colorectal Cancer.
    J Natl Cancer Inst. 2019 Jul 29. pii: 5537700. doi: 10.1093.
    PubMed     Text format     Abstract available

    Lancet Gastroenterol Hepatol

  34. KLAVER CEL, Wisselink DD, Punt CJA, Snaebjornsson P, et al
    Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
    Lancet Gastroenterol Hepatol. 2019 Jul 29. pii: S2468-1253(19)30239.
    PubMed     Text format     Abstract available


  35. HU YB, Yan C, Mu L, Mi YL, et al
    Correction: Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
    Oncogene. 2019 Jul 31. pii: 10.1038/s41388-019-0863.
    PubMed     Text format     Abstract available

    PLoS One

  36. MIZUNO H, Yuasa N, Takeuchi E, Miyake H, et al
    Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer.
    PLoS One. 2019;14:e0220579.
    PubMed     Text format     Abstract available

  37. TAIBI A, Albouys J, Jacques J, Perrin ML, et al
    Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging.
    PLoS One. 2019;14:e0220360.
    PubMed     Text format     Abstract available

  38. ZHAO Y, Yi C, Zhang Y, Fang F, et al
    Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2019;14:e0220533.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.